PMID: 11315348Apr 24, 2001Paper

Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations

Lupus
W W Ting, R D Sontheimer

Abstract

Local therapeutic measures should be maximized in the management of lupus erythematosus (LE), particularly for patients with forms of LE-specific skin disease such as SCLE and CCLE. Local therapy consists of sun protection and locally-applied pharmacologic agents, e.g. topical/intralesional corticosteroids. Patients should be advised to avoid direct sun exposure, wear lightweight tightly woven clothing and broad-brimmed hats, and use broad-spectrum, water-resistant sunscreens. There are several modalities that enhance permeability of local therapeutics through the stratum corneum that could be applied to topical therapy of cutaneous LE, e.g. polar solvent, liposomal encapsulation, ethosomal system, iontophoresis, electroporation and sonophoresis. As novel and more effective modalities to deliver pharmacologic agents across the stratum corneum become available, therapeutics that have been experimental and untested thus far may become part of the local armamentarium in the near future. In addition, physical/contact therapy as well as dermatosurgical methods can be invaluable in enhancing self-image and quality of life of patients with disfiguring cutaneous LE lesions.

References

May 1, 1977·The Journal of Dermatologic Surgery and Oncology·H H Roenigk
Sep 1, 1992·The British Journal of Dermatology·D DarrS Pinnell
Jan 1, 1992·The British Journal of Dermatology·J A Johnson
Jan 1, 1992·Dermatology : International Journal for Clinical and Investigative Dermatology·J ShupackL Jondreau
Nov 20, 1991·JAMA : the Journal of the American Medical Association·N LevineV J Hruby
Jan 17, 1991·The New England Journal of Medicine·UNKNOWN Canadian Hydroxychloroquine Study Group
Mar 1, 1991·Archives of Dermatology·E T KayeR R Anderson
Apr 1, 1991·Archives of Dermatology·M S LeeW D James
Jun 1, 1991·The Journal of Investigative Dermatology·H K ChoiG L Flynn
Apr 1, 1990·The Journal of Investigative Dermatology·B V DawsonV J Hruby
Feb 1, 1990·Journal of the American Academy of Dermatology·D Ratner, J W Skouge
Apr 1, 1989·Clinical Immunology and Immunopathology·K TakabayashiS Yoshida
May 1, 1989·Journal of Pharmaceutical Sciences·Y W ChienJ C Liu
May 1, 1989·Journal of Pharmaceutical Sciences·J B PhippsG A Lattin
Aug 1, 1987·Journal of the American Academy of Dermatology·S G Green, W W Piette
Oct 1, 1987·The Journal of Investigative Dermatology·S M Al-SaidanA J Winfield
Jan 1, 1986·Lasers in Surgery and Medicine·D L Henderson, J C Odom
Jan 1, 1995·Archives of Dermatological Research·F FurukawaM Takigawa
Jun 1, 1995·Journal of Pharmaceutical Sciences·S MitragotriR Langer
Dec 1, 1994·The Clinical Investigator·M Schäfer-KortingE Ponce-Pöschl
Dec 1, 1994·Nature·M S EllerB A Gilchrest
Mar 1, 1994·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·H Ueki
May 31, 1993·Annals of the New York Academy of Sciences·M E HadleyR T Dorr
Dec 1, 1995·The British Journal of Dermatology·M NúñezA Ledo
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M S EllerB A Gilchrest
Apr 1, 1996·Journal of the American Academy of Dermatology·D G KassanM J Stiller
Oct 1, 1996·Journal of the American Academy of Dermatology·K L MaggioW D James
Oct 1, 1996·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·W NürnbergG Kolde
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Apr 1, 1997·Biopharmaceutics & Drug Disposition·S O UgwuV J Hruby
Feb 3, 1998·Journal of the American Academy of Dermatology·B Eberlein-KönigB Przybilla
Aug 8, 1998·Ultrasound in Medicine & Biology·J WuL Weimann
Oct 7, 1998·Pharmaceutical Biotechnology·M E HadleyT K Sawyer
Dec 2, 1998·Pharmaceutical Research·T HikimaK Tojo
Jan 26, 1999·Annals of the New York Academy of Sciences·V P Zharov, A S Latyshev
Feb 11, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·M KirjavainenJ Mönkkönen
May 18, 1999·Archives of Dermatology·T RuzickaB Homey
Jun 17, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·J Y FangC L Fang
Jul 9, 1999·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·E HorwitzE Touitou

❮ Previous
Next ❯

Citations

Sep 18, 2008·Archives of Dermatological Research·Miklós SárdyAnnegret Kuhn
Dec 3, 2011·Annals of Biomedical Engineering·Prakriti Parijat, Thurmon E Lockhart
May 1, 2002·Current Opinion in Rheumatology·Daniel J Wallace
Mar 9, 2011·Biologics : Targets & Therapy·Michael Sticherling
Apr 28, 2010·Therapeutics and Clinical Risk Management·Christos E Lampropoulos, David P D'Cruz
Apr 19, 2002·Paediatric Drugs·Luis CarreñoIndalecio Monteagudo
Mar 15, 2014·Anais Brasileiros De Dermatologia·Jucélio Pereira Moura FilhoEutilia Andrade Medeiros Freire
Jun 10, 2009·Expert Opinion on Pharmacotherapy·Lisa Francis, Andras Perl
Nov 22, 2005·Expert Opinion on Drug Delivery·Josbert M Metselaar, Gert Storm
Dec 24, 2005·Autoimmunity·Annegret Kuhn, Stefan Beissert
Aug 27, 2010·Journal of the American Academy of Dermatology·Annegret KuhnGisela Bonsmann
Sep 13, 2006·Clinics in Dermatology·Naomi RothfieldMegan Bernstein
Jun 4, 2002·Best Practice & Research. Clinical Rheumatology·Marilyn A Solsky, Daniel J Wallace
May 25, 2004·Expert Opinion on Pharmacotherapy·Richard D Sontheimer
Mar 13, 2015·Current Rheumatology Reports·Zehra Serap ArıcıSeza Ozen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
S MellerB Homey
Journal of the European Academy of Dermatology and Venereology : JEADV
U Wollina, G Hansel
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete
D BacmanAnnegret Kuhn
© 2021 Meta ULC. All rights reserved